GUANGZHOU-INFORMATION
18.11.2023 13:07:35 CET | Business Wire | Press release
China’s Guangzhou launched a special conversation on November 16 in Italy’s Rome, at which more than a dozen guests from both countries told their stories about cultural and economic cooperation, showcased the fruitful achievements between two sides.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231118396482/en/
China’s Guangzhou launches conversations between China and Italy to showcase the cooperation achievements. (Graphic: Business Wire)
Guangzhou, a metropolis in southern China, has been a trade gateway of China to the world for more than two thousand years.
According to Sun Yong, publicity director of Nansha District of Guangzhou, “At that time, Guangzhou received merchant ships from all over the world including Italy, when marked the prosperity of Maritime Silk Road.”
“Today, the world's largest luxury ro-ro passenger ship MOBY, operating in the Italian Mediterranean, was actually built by Guangzhou Shipyard International based in Nansha,” Sun continued, “we are still connected.”
Michele De Gasperis, President of the Italian One Belt One Road Institute, said that Guangzhou is not only a beautiful city, but also a city full of business opportunities.
“Recently I visited the Canton Fair held in Guangzhou and was deeply impressed. I firmly believe that Guangzhou will become an important trade and tourism destination in Italy,” said Gasperis.
During the event, the Italian pianist Giuseppe Ganzerli, performed with PEARL River piano. “I started to import Pearl River piano from Guangzhou for more than ten years. Pearl River is a beautiful river across Guangzhou city. I always tell my Italian clients that this piano is so beautiful just like the Pearl River itself,” said Gennaro Schlitzer, board member of Queen’s SRL.
Several chefs from Guangzhou Restaurants Group demonstrated Guangzhou cuisine at the event.
“Canton is famous for its unique cuisine, which has reached every corner of the world. But our relationship goes far beyond cooking,” Angelo Tabaro, former minister for culture of the Veneto Region said.
“Italy and China are the two nations with the longest-lived and richest cultural heritages.” He added, “From painting to music, literature to architecture, both countries have influenced the world in unique ways. Italian and Chinese companies collaborate in sectors ranging from automobiles to fashion, from technology to renewable energy.”
Edouard Suzeau, a young designer from Guangzhou Automobile Group (GAC) Design Studio Milan, said that “Milan was chosen as the location for our studio because the city’s ubiquitous car culture is a perfect fit with GAC’s mission and passion for automotive design.”
A modern sculpture called Embrace the World made by Guangzhou artist Zeng Zhenwei, was given to Laura Gallon, President of the Italian Arte Laguna Prize. “I believe that the art and culture exchange between our two nations can be carried forward,” Gallon said.
Statistic shows that in 2022, the bilateral trade volume between China and Italy reached US$77.9 billion, hit a record high.
“More exchanges in all sectors are expected,” Li Ran from China southern airlines said, “For example, we currently operate four round-trip flights per week between Guangzhou and Rome, and will increase to six per week in December this year.”
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231118396482/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
First Plus Expands Relationship with SS&C to Support Cross-Border Operations in APAC3.8.2026 03:00:00 CEST | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that First Plus Asset Management (FPAM), a multi-asset investment management firm, has selected SS&C to provide cross-border operations support across Asia. SS&C will service First Plus across the full investment lifecycle, delivering a scalable, integrated solution supporting transfer agency, order management and execution and investment accounting. FPAM will utilize SS&C to service its growing cross-border operating model and support around $200 million in assets under management*. “As First Plus has expanded, managing our operations has become increasingly complex,” said Jeb Li, Co-Founder and CEO at First Plus. “SS&C’s global footprint and integrated offerings enable us to easily optimize our workflows, so we can focus on scaling quickly and securely while continuing to deliver risk-adjusted returns and best-in-class client service.” The engagement highlights the breadth and scalability of SS&C’s global service model.
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
